Market size of Bio-Tech Sector

The Indian agricultural sector is predicted to increase to US$ 24 billion by 2025. India can be among the top five exporters of agro-commodities by shifting its focus on cultivation and effectively handholding farmers

The biotechnology sector in India is witnessing a strong growth trajectory and has proved to be highly inventive

India is among the top 12 biotechnology destinations in the world and the third-largest in the Asia-Pacific region.

The Indian biotech industry holds 3% of the global market share.

The Indian bioeconomy grew from US$ 70.2 billion in 2020 to US$ 80.12 billion in 2021, growing at 14.13%.

A total of 1,128 biotech startups were launched in 2021.

The Indian biotechnology industry is likely to reach US$ 150 billion by 2025.

Opportunities in various segments

  • All
  • BIO-Services
  • Bio-Industrials
  • Bio-Pharma
  • Bio-Agri
  • Bio-IT


India has potential for clinical trials due to alarge and low-cost market.

Clinical trials in India are regulated by the Central Drug Standard Control Organisation, which has reduced approval time to about 30-60 days


Biofuels and bioenergy are considered alternative resources and are gaining popularity in India.

Rise in energy demand is leading to an increase in dependence on fossil fuel imports.


The Indian biologics market is expected to register a CAGR of 22% from 2019 to 2025, to reach US$ 12 billion by 2025.

The Indian biologics market is expected to register a CAGR of 22% from 2019 to 2025.


India’s Union budget 2021-22 stated the government’s plan to enhance farm productivity and focus on food security.

This increased the importance of bioagriculture, which will enhance efficient food production.


Biotechnology has immense growth potential in the Bio-IT segment, given the rising need for technology.

India’s IT industry is witnessing substantial growth and has the requisite IT infrastructure to cater to the needs of the global Bio-IT industry.

biotech investment trends

India is likely to witness > 100million diabetics by 2030.With the rising number of patients,~50% are undiagnosed,providing domestic market opportunity to the country.

Why We Choose

bio technology industry
GHL INDIA is here to create a prosperous environment that serves the world at large

Let us join together to live an opulent life